Walgreens Boots Alliance (WBA) Tops Q4 EPS by 3c, Offers FY23 Guidance

Walgreens Boots Alliance (NASDAQ: WBA) reported Q4 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $32.4 billion versus the consensus estimate of $32.07 billion.

GUIDANCE:

Walgreens Boots Alliance sees FY2023 EPS of $4.45-$4.65, versus the consensus of $4.53.

• Expecting fiscal year 2023 adjusted EPS of $4.45 to $4.65 as strong core business growth is more than offset by lapping fiscal year 2022 COVID-19 execution, and currency headwinds
• Raising U.S. Healthcare fiscal 2025 sales target to $11 billion to $12 billion, with the segment expected to achieve positive adjusted EBITDA by fiscal year 2024
• Increased visibility to the company's long-term growth algorithm, building to low-teens adjusted EPS growth in fiscal year 2025 and beyond

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.

You May Also Be Interested In

• Analysts defend Broadcom as annual guidance falls short after FQ4 earnings beat
• Verint Systems adds 10% after earnings, upside credited to 'rising adoption of AI and Bots'
• RH (RH) shares tumble as 'frozen' housing market weighs on results